ARTED's 16th Ordinary General Assembly Was Held
The 16th Ordinary General Assembly Meeting of ARTED was held on 20 February 2026 with the participation of ARTED members. During the meeting, ARTED’s Activity Report and Audit Board Report for the 2024–2026 term were reviewed and approved, and the governance structure for the new term was determined.
Following the General Assembly, Gürdal Şahin, Deputy General Manager responsible for Laboratory Diagnostics and Innovation Management at Siemens Healthineers, was elected as Chairman of the Board of Directors.
For the new term, the positions of Vice Chair will be held by Nilüfer Özkan, General Manager of bioMérieux Türkiye, and Serhan Acar, Senior Director, HEMA & Public Affairs GEM & Mid-Size European Markets at Boston Scientific.
The other members of the Board of Directors are Ceylan Yokuş, General Manager of Johnson & Johnson MedTech Surgery Türkiye & RCIS and Türkiye Campus Leader, and Mustafa Emre Sevinç, Country Leader of Medtronic Türkiye.
The Substitute Members of the Board of Directors for the new term were appointed as Vecihe Özek, General Manager of Getinge Group; Ulaş Emiroğlu, Country Director of Baxter Türkiye; Tülin Gündem, General Manager of Smith+Nephew; Onur Minare, General Manager, Diagnostics Division for Central and Eastern Europe, Türkiye, TRNC and CIS at Abbott; and Umut Gökalp, Regional General Manager for Europe, the Middle East, Türkiye and Africa at Sysmex.
The Audit Board members elected by the General Assembly are Barış Arslan, Country Director of Zeiss Türkiye; Gamze Arbak, General Manager of Philips Türkiye; and Berna Ünses, Commercial Operations Director for Türkiye and Azerbaijan at Beckman Coulter.
In his remarks following the General Assembly, ARTED Chairman of the Board Gürdal Şahin emphasized that ARTED will continue its efforts with determination in the new term to strengthen public–private sector collaboration, contribute to the development of healthcare policies, support the generation of sectoral data, and improve access to innovative medical technologies.
Şahin also stated that Ferda Bayşu will continue to lead the ARTED Secretariat, which plays a key role in fostering collaboration among sector stakeholders, maintaining effective dialogue with public institutions, and coordinating the Association’s strategic initiatives.